Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemo/Brachytherapy vs Chemotherapy in Cervical Cancer
NCT03243825Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Nov 2012
- Primary completion
- Jun 2015
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Proportion of post-operative chemo-radiotherapy at 2 months. Started Nov 2012; status: completed.
Beyond the preview
Go deeper on NCT03243825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03243825.